Ollin Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-24.
Announced $330M on 2026-06-24; Form D shows $156.2M sold as of 2026-06-24. Announced vs filed
Ollin Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 24, 2026. The filing reports $156.25M sold. Its industry group is Biotechnology. It names Jason Ehrlich (Executive Officer, Director), Paul Berns (Director), Jason Coloma (Director) (SEC Form D, June 24, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Ollin Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-06-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Ollin Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Ollin Biosciences, Inc., from the filings we hold.
Biotechnology raises by companies based in Texas, filed in June 2026, largest first.
Get an email when Ollin Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Ollin Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Ollin Biosciences, Inc. →Get the full cited report on Ollin Biosciences, Inc.
What the filing shows about Ollin Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ollin Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Ollin Biosciences, Inc.'s address as 1250 S. Capital Of Texas Hwy, Building 3, Suite 400, Austin, TX 78746.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Ollin Biosciences, Inc. See pricing
Ollin Biosciences, Inc. is a registered filer with the SEC (CIK 2141184) and has filed since 2026-06-24. 1 filing is on record, the latest on 2026-06-24.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Ollin Biosciences, Inc.'s Form D of 2026-06-24 names Jason Ehrlich, Paul Berns, Jason Coloma and 4 more as its officers, directors or promoters.
Its new offerings report $156.25M sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $156.25M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Jason Ehrlich is named as Executive Officer and Director on the Form D that Ollin Biosciences, Inc. filed with the SEC on 24 June 2026, one of 7 people that filing names.
Paul Berns is named as Director on the Form D that Ollin Biosciences, Inc. filed with the SEC on 24 June 2026, one of 7 people that filing names.
Jason Coloma is named as Director on the Form D that Ollin Biosciences, Inc. filed with the SEC on 24 June 2026, one of 7 people that filing names.
Cariad Chester is named as Director on the Form D that Ollin Biosciences, Inc. filed with the SEC on 24 June 2026, one of 7 people that filing names.
Fred Cohen is named as Director on the Form D that Ollin Biosciences, Inc. filed with the SEC on 24 June 2026, one of 7 people that filing names.
Alaa Halawa is named as Director on the Form D that Ollin Biosciences, Inc. filed with the SEC on 24 June 2026, one of 7 people that filing names.
Travis Murdoch is named as Director on the Form D that Ollin Biosciences, Inc. filed with the SEC on 24 June 2026, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2026-06-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Ollin Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ollin Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ollin Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Ollin Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Ollin Biosciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Ollin Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Austin
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ollin-biosciences-inc-form-d-26000002